Patent · US Active

Preparation method of sustained-release microparticles

US12186432B2 · kind B2 · utility

0Cited by
2References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 2, 2021
Grant dateJan 7, 2025
Priority date
Expiry dateMar 29, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/34
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In the present invention, the whole preparation process of the sustained-release microparticles is at normal or low temperature, which is highly advantageous for the preparation of a polymer-based composition from a high-temperature-sensitive drug, particularly a protein, nucleic acid and peptide drug, and the bioactivity of the active substance can be maintained to the greatest extent throughout the process compared to the disclosed technology; at the same time, the prepared sustained-release microparticles have an excellent sustained-release effect close to zero order, and the drug concentration is stabilized during the release, which overcomes the defects that the microparticles obtained by the conventional S/O/W process of pre-preparing the drug microparticles have no drug release in the earlier stage and a rapid release of the drug in the later stage; and in addition, the sustained-release microparticles have higher drug loading rate and drug encapsulation rate.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.